Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Idorsia Pharmaceuticals synthesizes LGALS inhibitors

March 24, 2021

Bristol Myers Squibb divulges DGKA and/or DGKZ inhibitors

March 24, 2021

U.S. researchers patent GTPase KRAS mutant inhibitors

March 24, 2021

MGTA-145 plus plerixafor effectively mobilizes stem cells for transplant in phase I study

March 24, 2021

Japanese MHLW approves Pemazyre for unresectable biliary tract cancer with FGFR2 fusion gene

March 23, 2021

Phase III VISION study of 177Lu-PSMA-617 meets primary endpoints in CRPC

March 23, 2021

Incyte synthesizes adenosine A2A and/or A2B receptor antagonists

March 23, 2021

Avalon Globocare and MIT expand their codevelopment program

March 23, 2021

FDA approves IND application for CBX-12

March 23, 2021

Odonate Therapeutics discontinues development of tesetaxel

March 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....